Clinical relevance of cell-free DNA quantification and qualification during the first month after lung transplantation

BackgroundMany studies have reported the relevance of donor-derived cfDNA (dd-cfDNA) after lung transplantation (LTx) to diagnose and monitor acute rejection (AR) or chronic rejection or infection (INF). However, the analysis of cfDNA fragment size has not been studied. The aim of this study was to determine the clinical relevance of dd-cfDNA and cfDNA size profiles in events (AR and INF) during the first month after LTx.MethodsThis prospective, single-center study includes 62 LTx recipients at the Marseille Nord Hospital, France. Total cfDNA quantification was performed by fluorimetry and digital PCR, dd-cfDNA by NGS (AlloSeq cfDNA-CareDX®), and the size profile by BIABooster (Adelis®). A bronchoalveolar lavage and transbronchial biopsies at D30 established the following groups: not-injured and injured graft (AR, INF, or AR+INF).ResultsQuantification of total cfDNA was not correlated with the patient’s status at D30. The percentage of dd-cfDNA was significantly higher for injured graft patients at D30 (p=0.0004). A threshold of 1.72% of dd-cfDNA correctly classified the not-injured graft patients (negative predictive value of 91.4%). Among recipients with dd-cfDNA >1.72%, the quantification of small sizes (80-120bp) >3.70% identified the INF with high performance (specificity and positive predictive value of 100%).ConclusionWith the aim of considering cfDNA as a polyvalent non-invasive biomarker in transplantation, an algorithm combining the quantification of dd-cfDNA and small sizes of DNA may significantly classify the different types of allograft injuries

The polymorphism of KIR genes in worldwide human populations

Résumé de colloque 22nd European Immunogenetics and histocompatibility conference - 02-05 avril 2008 - Toulouse France Tissue antigens - vol.71 n°

Characterization of 43 novel HLA-H alleles.

Forty‐three novel HLA‐H alleles, including 32 identified in cohorts of French donors for Hematopoietic Stem Cell Transplantation, have been characterized by Next‐Generation Sequencing (NGS) using a long range PCR approach. A phylogenetic study confirms three main HLA‐H clades

Characterization of the novel HLA‐B*07:482 allele using next‐generation sequencing methods

HLA‐B*07:482 differs from HLA‐B*07:02:01:01 allele by one nucleotide substitution in codon 285 in exon 5

Characterization of the novel HLA‐A*33:246 allele using next‐generation sequencing

HLA‐A*33:246 differs from HLA‐A*33:01:01:01 allele by one nucleotide substitution in codon 135 in exon 3

The novel HLA-DQA1*03:01:12 allele identified using next-generation sequencing in a Melanesian individual.

HLA‐DQA1*03:01:12 differs from HLA‐DQA1*03:01:01:01 by one nucleotide substitution in codon 21 in exon 2

KIR2DL4 and HLA-G allelic polymorphism in human populations and in hematopoietic stem cell transplantation

Résumé de colloque 15th international histocompatibility and immunogenetics workshop and Conference - 23-20 septembre 2008 - Rio de Janeiro Brazil Tissue antigens - vol.72 n°